Royalty Pharma plc has announced a significant update to its financial arrangements with the entry into a Joinder, Release and First Amendment to its Loan Agreement and Loan Documents. Following the consummation of a transaction, RP Management has been released as a borrower under the existing loan agreement and guaranty, which were originally dated December 11, 2023. In their place, RPH and RP LLC have been joined as borrowers and guarantors under the amended agreements. Additionally, the Entity Guarantors, Legorreta Investments and Legorreta Investments II LLC, along with Individual Guarantor Pablo Legorreta, have confirmed their ongoing obligations under the revised terms. This amendment signifies the restructuring of Royalty Pharma's financial commitments in collaboration with Bank of America, N.A.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.